Did FDA-App Recalls and Activist Pressure Just Rewire Dexcom’s (DXCM) Software-Driven Investment Narrative?

Simply Wall St. · 2026-06-03T01:07:46Z

2 Growth Stocks to Buy and Hold for a Decade

Motley Fool · 2026-06-02T19:20:00Z

TNDM Stock: What to Know About Tandem's 2026 Reset

Zacks · 2026-06-02T14:56:00Z

How The DexCom (DXCM) Investment Story Is Shifting With New Guidance And Valuation Resets

Simply Wall St. · 2026-05-27T15:08:20Z

Signos raises $20M, expands Dexcom partnership for weight loss

Quartz · 2026-05-27T13:44:15Z

Live Longer and Better. Does ’Biohacking’ Really Work?

Barrons.com · 2026-05-26T13:24:00Z

S&P 500 Posts Eighth Consecutive Weekly Gain Led by Health Care, Utilities

MT Newswires · 2026-05-22T20:48:22Z

DexCom Flex Launch Targets Wider Type 2 Market With Valuation Upside

Simply Wall St. · 2026-05-22T20:14:58Z

Harnessing medtech market alliances, ŌURA sets IPO plans in motion

Medical Device Network · 2026-05-22T15:12:25Z

Analysts Upgrade DexCom (DXCM) to “Outperform,” Driving Share Recovery

Insider Monkey · 2026-05-22T12:37:21Z